About

About Qentoros

The values that guide our science — and the veterinary scientists and clinicians building the next generation of equine therapeutics.

Our values

How we work

Lab to clinic

BIO-PLY™ began in a leading equine research lab and was spun out with its inventors at the helm, building therapeutics on a foundation of peer-reviewed science.

Outcomes that matter

We measure success by horses returning to work. In our pilot trial, treated horses returned to athletic performance at far higher rates than historical norms.

Pharmaceutical-grade rigor

BIO-PLY™ is manufactured under cGMP from a closed, disease-screened herd, with strict release criteria and per-lot activity testing before any product ships.

Leadership

The people leading Qentoros

A founding team that spans bench science, equine surgery, and regulatory rigor.

Jessica Gilbertie

Chief Executive Officer

  • MS
  • DVM
  • PhD

Jessica is a veterinary scientist and co-inventor of BIO-PLY™. She leads Qentoros’s strategy and operations, translating peptide biology from the bench into therapies veterinarians can rely on every day.

View profile

Lauren Schnabel

Chief Medical Officer

  • DVM
  • PhD
  • DACVS
  • DACSMR

Lauren is a board-certified equine surgeon and sports medicine specialist. She guides clinical strategy at Qentoros, ensuring our therapies and trial designs hold up to the highest standard of veterinary care.

View profile

Partner with us

Whether you’re a veterinarian, researcher, or investor, we would love to hear from you.